Literature DB >> 23667203

Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

Al B Benson1, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A Choti, Harry S Cooper, Paul F Engstrom, Peter C Enzinger, Marwan G Fakih, Moon J Fenton, Charles S Fuchs, Jean L Grem, Steven Hunt, Ahmed Kamel, Lucille A Leong, Edward Lin, Kilian Salerno May, Mary F Mulcahy, Kate Murphy, Eric Rohren, David P Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M Skibber, William Small, Constantinos T Sofocleous, Alan P Venook, Christopher G Willett, Kristina M Gregory, Deborah A Freedman-Cass.   

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions regarding the treatment of localized disease for the 2013 update of the guidelines.

Entities:  

Mesh:

Year:  2013        PMID: 23667203     DOI: 10.6004/jnccn.2013.0069

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  40 in total

1.  Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.

Authors:  F Bianco; A Arezzo; F Agresta; C Coco; R Faletti; Z Krivocapic; G Rotondano; G A Santoro; N Vettoretto; S De Franciscis; A Belli; G M Romano
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

2.  Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

Authors:  Waleed Shady; Sirish Kishore; Somali Gavane; Richard K Do; Joseph R Osborne; Gary A Ulaner; Mithat Gonen; Etay Ziv; Franz E Boas; Constantinos T Sofocleous
Journal:  Eur J Radiol       Date:  2016-03-31       Impact factor: 3.528

Review 3.  Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.

Authors:  Oscar Murcia; Miriam Juárez; Eva Hernández-Illán; Cecilia Egoavil; Mar Giner-Calabuig; María Rodríguez-Soler; Rodrigo Jover
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

4.  The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.

Authors:  Tsuyoshi Ozawa; Soichiro Ishihara; Takeshi Nishikawa; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2015-06-07       Impact factor: 2.571

5.  Expression and clinical significance of mammalian target of rapamycin/P70 ribosomal protein S6 kinase signaling pathway in human colorectal carcinoma tissue.

Authors:  Qingjun Lu; Jieshu Wang; Gang Yu; Tianhua Guo; Chun Hu; Peng Ren
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

6.  The role of adjuvant chemotherapy in stage II colorectal cancer patients.

Authors:  Hung-Hsin Lin; Yu-Yao Chang; Jen-Kou Lin; Jeng-Kai Jiang; Chun-Chi Lin; Yuan-Tzu Lan; Shung-Haur Yang; Huann-Sheng Wang; Wei-Shone Chen; Tzu-Chen Lin; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2014-07-15       Impact factor: 2.571

Review 7.  CT colonography in the diagnosis and management of colorectal cancer: emphasis on pre- and post-surgical evaluation.

Authors:  Nurhee Hong; Seong Ho Park
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 8.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.

Authors:  Hoang Dinh Tuy; Hisanori Shiomi; Ken Ichi Mukaisho; Shigeyuki Naka; Tomoharu Shimizu; Hiromichi Sonoda; Eiji Mekata; Yoshihiro Endo; Yoshimasa Kurumi; Hiroyuki Sugihara; Masaji Tani; Tohru Tani
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

Review 10.  Colorectal cancer in young adults.

Authors:  Jennifer A Inra; Sapna Syngal
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.